| 000 | 01413 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512213953.0 | ||
| 264 | 0 | _c19850325 | |
| 008 | 198503s 0 0 eng d | ||
| 022 | _a0021-9681 | ||
| 024 | 7 |
_a10.1016/0021-9681(84)90069-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSuwanogool, S | |
| 245 | 0 | 0 |
_aDrug-resistance encountered in the retreatment of Mycobacterium tuberculosis infections. _h[electronic resource] |
| 260 |
_bJournal of chronic diseases _c1984 |
||
| 300 |
_a925-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aAminosalicylic Acid _xtherapeutic use |
| 650 | 0 | 4 |
_aAntitubercular Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aPatient Readmission |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRifampin _xtherapeutic use |
| 650 | 0 | 4 |
_aStreptomycin _xtherapeutic use |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdrug therapy |
| 700 | 1 | _aSmith, S M | |
| 700 | 1 | _aSmith, L G | |
| 700 | 1 | _aEng, R | |
| 773 | 0 |
_tJournal of chronic diseases _gvol. 37 _gno. 12 _gp. 925-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0021-9681(84)90069-9 _zAvailable from publisher's website |
| 999 |
_c6441697 _d6441697 |
||